Frailty - UpToDate

Frailty - UpToDate https://www.uptodate.com/contents/frailty/print?search=frailty&source=...
Official reprint from UpToDate®

www.uptodate.com © 2023 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
Frailty
��: Jeremy D Walston, MD
�� : Kenneth E Schmader, MD
�� : Jane Givens, MD, MSCE
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: Jun 2023.

This topic last updated: Jun 12, 2023.
INTRODUCTION
Frailty is most often defined as an aging-related syndrome of physiological decline,

characterized by marked vulnerability to adverse health outcomes. Frail older patients often
present with an increased burden of symptoms including weakness and fatigue, medical
complexity, and reduced tolerance to medical and surgical interventions. Awareness of frailty
and associated risks for adverse health outcomes can improve care for this most vulnerable
subset of patients.
Although there is no gold standard for detecting frailty, multiple frailty screening tools have
been developed and utilized for risk assessment and epidemiologic study.
This topic will review the definitions, pathophysiology, prevalence, and diagnosis of frailty and
clinical approaches that may attenuate vulnerability and relieve symptoms.
PREVALENCE
Many population-based studies of frailty have been performed using a variety of frailty
measures. Although the prevalence of frailty varies with the tool used and with the population
studied, prevalence in several studies in the United States ranges from 4 to 16 percent in
community-dwelling men and women aged 65 and older [1-5] and up to 43 percent of older
patients with cancer [6]. Pre-frailty (patients at risk for frailty who fulfill some, not but all,
criteria for frailty) has a prevalence ranging from 28 to 44 percent in those over 65 years old
1 de 30 08-07-2023, 15:10
[1,4,5].
A 2012 systematic review found that when frailty was defined on the basis of physical findings
alone, overall prevalence in 15 studies (44,894 participants) was 9.9 percent; when
psychosocial aspects were included in the definition, prevalence was 13.6 percent among
eight studies (24,072 participants) [7]. In a European study (the Survey of Health, Ageing, and
Retirement in Europe [SHARE]) comparing eight frailty scales, frailty prevalence ranged from 6
to 44 percent when applied to a database of individuals aged 50 to 104 years [8]. In a US study
of people aged 90 and older, the prevalence of frailty was 24 percent for those aged 90 to 94
and 39.5 percent for those 95 and older [9].
In a study in the United States of nearly 6000 community-dwelling men aged 65 and older, at
an average follow-up of 4.6 years, 54.4 percent of men who were robust at baseline remained
robust, 25.3 percent became pre-frail, 1.6 percent became frail, 5.7 percent died, and the
remainder could not be assessed [5].
HEALTH CONSEQUENCES AND MORTALITY
Frail older adults are less able to tolerate and adapt to stressors such as acute illness, surgical
or medical interventions, or trauma than younger or non-frail older adults. This increased
vulnerability contributes to increased risk for procedural complications, falls,
institutionalization, disability, and death [10]. After adjustment for comorbidities, frailty
predicts hip fractures, disability, and hospitalization [4]. Frailty also predicts adverse outcomes
related to renal transplantation, general surgery (elective and emergency), and cardiac
surgery interventions [11-15]. As such, frailty in older patients is considered to be the hallmark
geriatric syndrome that is a forerunner to other geriatric syndromes, including frequent falls,
fractures, delirium, cognitive impairment, and incontinence.
Frailty is associated with increased mortality:
● In the longitudinal Women's Health Initiative Observational Study, mortality was

increased in those with baseline frailty (HR 1.71; 95% CI 1.48-1.97) [4].
● In a study in men, mortality was twice as high for frail, compared with robust men (HR
2.05; 95% CI 1.55-2.72) [5].
● In a European study, mortality was best predicted by the Frailty Index and Edmonton
2 de 30 08-07-2023, 15:10
scales, with death rates three to five times higher in cases classified as frail compared
with those not classified as frail [8].
● In analysis of data from the Longitudinal Aging Study Amsterdam, in which 2874 adults
aged 64 to 84 years were followed for 21 years, frailty (defined as ≥0.25 on the 32-item
frailty index) was associated with greater four-year mortality (odds ratio [OR] 2.79, 95%
CI 2.39-3.26) [16].
● In a cohort study of over two  million United States veterans aged 65 years or older, the
risk of suicide attempt was higher in patients with all levels of frailty (prefrailty and mild,
moderate, and severe frailty) compared with those without frailty, as measured by the
frailty index assessing morbidity, function, sensory loss, cognition and mood, and other
functions [17].
CONCEPTS AND DEFINITIONS
Overview — It is generally recognized that the term “frailty” captures the essence of age-
related vulnerability and decline, and that it can be useful in clinical practice [18,19]. At
present, there are two major conceptual frameworks for the term “frailty” that have influenced
the development of multiple frailty measurement tools.
● Physical frailty, often termed phenotypic or syndromic frailty, was developed in part to
capture representative signs and symptoms (fatigue, low activity, weakness, weight loss,
and slow gait) of community-dwelling older adults that were most vulnerable to adverse
health outcomes.
● Deficit accumulation frailty or index frailty was developed around a conceptual

framework that identifies the most frail, vulnerable older adults through cumulative
comorbidities and cumulative illnesses as frail.
In both physical frailty and deficit accumulation frailty, advanced frailty is consistent with
advanced vulnerability. Indeed, comparability studies have found that those who are most
vulnerable can be found by either tool. However, substantial discordance at individual level
classifications exists between the conceptual frameworks in the more intermediate levels of
frailty [20].
Acceptance of a standardized definition for frailty in clinical practice has been slowed in part
by a proliferation of frailty measurement tools with differing conceptual bases and that often
fail to differentiate between disability, comorbidity, and frailty. A summary of conceptual
3 de 30 08-07-2023, 15:10
commonalities includes [18,19,21,22]:
● Multiple factors (medical, environmental, educational, and psychological background)

impact frailty, functional status and physiologic reserve among older adults.
● Age, chronic comorbidities, and disability, while associated with frailty, do not establish
the diagnosis of frailty [1,22-24].
● Frailty exists on a spectrum. The end stage of the continuum of frailty is often considered
to be failure to thrive. (See "Failure to thrive in older adults: Evaluation" and "Failure to
thrive in older adults: Management".)
Old age itself does not define frailty. Many older adults remain vigorous, despite advanced
age, while others have gradual yet unrelenting functional decline in the absence of apparent
disease states, or failure to rebound following illness or hospitalization.
Instruments developed to identify frailty — Efforts to incorporate frailty measurement

tools into both subspecialty and primary care practices continue to increase [25,26]. Over the
past several years, multiple frailty assessment tools have been developed to help identify frail
patients. Most have been validated in their ability to identify those individuals at highest risk
for adverse health outcomes in a variety of clinical settings.
A 2016 comprehensive review of the most frequently cited frailty measurement tools identified
67 different frailty instruments, capturing varying domains and criteria depending upon the
intended use of the instrument [27]. A subsequent study found a wide range of agreement (no
agreement to almost complete agreement) among these instruments when tested in the
same population [28].
The majority of screening tools used to determine frailty status have been developed based
upon one of two concepts: "physical" or "phenotypic" frailty versus "deficit accumulation" or
"index" frailty [25,29,30] (see 'Overview' above). Physical or phenotypic frailty is thought to
result from multisystem biological decline leading to specific symptoms such as weight loss,
weakness, and walking speed. Deficit accumulation or index frailty is measured by tabulating
the combination of comorbidities, social situations, and disabilities (rather than a specific
biology per se) to assess risk.
The physical frailty screening tool most often cited is often called the Fried Frailty Tool or
Frailty Phenotype [27]. This tool was developed to identify physical frailty in community-
dwelling older adults and was validated in the Cardiovascular Health Study (CHS), which
involved over 5000 men and women aged ≥65 years [1], and multiple other studies
4 de 30 08-07-2023, 15:10
[11,12,31,32]. This tool requires patient participation and specialized equipment for grip
strength and walking speed measurements and defines the frailty phenotype as meeting
three or more of the following five criteria [1]. Pre-frailty is defined as one or two of these
characteristics, and not frail as having none:
● Weight loss (≥5 percent of body weight in last year)

● Exhaustion (positive response to questions regarding effort required for activity)
● Weakness (decreased grip strength)
● Slow walking speed (gait speed) (>6 to 7 seconds to walk 15 feet)
● Decreased physical activity (Kcals spent per week: males expending <383 Kcals and
females <270 Kcal)
The deficit accumulation or index approach to measuring frailty is based on the accumulation
of illnesses, functional and cognitive declines, and social situations that are added together to
calculate frailty [33]. It requires answering 20 or more medical and functional-related
questions. The higher the number of deficits, the higher the frailty score. The tool can be
adapted to information available in the medical record and does not require a patient
interview or exam for tabulation.
Although there may be biological connections between mild cognitive impairment/dementia

and frailty, the most commonly utilized physical frailty measurement tools do not incorporate
cognitive assessment [34]. However, frailty is associated with an increased risk of cognitive
decline [35,36]. In addition, the presence of cognitive impairment increases the likelihood of
adverse health outcomes in geriatric patients who meet criteria for physical frailty. In a 2011
systematic review of 22 articles addressing the definition of frailty, cognitive measurements
were commonly included in frailty screening, mostly in tools assessing frailty based on
cumulative deficits rather than physical frailty [21].
Rapid screening tools — Although the frailty phenotype assessment and the frailty index
approach are the most commonly cited and most validated approaches to frailty
measurement, clinicians and patients may benefit from using a quicker frailty screening
assessment tool. Such tools allow clinicians to more quickly flag vulnerable older adults and
work to alter care plans based on this vulnerability. Several studies have compared the most
commonly utilized screening tools and found that these indices were comparable in predicting
risk of adverse health outcomes and mortality [2,37,38].
In addition, several of the rapid screening tools described below can be utilized to identify
those who might need a more formal comprehensive geriatric assessment (CGA) [39].
5 de 30 08-07-2023, 15:10
A tool that takes only minutes to perform, and can be incorporated into the history-taking
part, is the FRAIL scale, which is presented in a slightly modified version below [40,41]. The
mnemonic "FRAIL" is helpful in remembering the component questions:
● Fatigue ("Have you felt fatigued? Most or all of the time over the past month?") Yes = 1,
No = 0
● Resistance ("Do you have difficulty climbing a flight of stairs?") Yes = 1, No = 0
● Ambulation ("Do you have difficulty walking one block?") Yes = 1, No = 0
● Illnesses (“Do you have any of these illnesses: hypertension, diabetes, cancer (other than
a minor skin cancer), chronic lung disease, heart attack, congestive heart failure, angina,
asthma, arthritis, stroke, and kidney disease?”) Five or greater = 1, fewer than 5 = 0
● Loss of weight (“Have you lost more than 5 percent of your weight in the past year?”)
Yes= 1, No = 0
Frail scale scores range from 0 to 5 (0 = best, 5 = worst) and represent frail (3 to 5), pre-frail (1
to 2), and robust (0) health status.
Another assessment tool known for its ease in administering in most clinical settings is The
Study of Osteoporotic Fractures (SOF) frailty tool [37]. Frailty is defined as the presence of at
least two of three components:
● Weight loss of 5 percent in last year;

● Inability to rise from a chair five times without use of arms; or
● A "no" response to the question "Do you feel full of energy?"
The Edmonton Frail Scale has 14 questions that cover a variety of important domains,
including cognition, general health, function, social support, and nutrition. This validated tool,
while not diagnosing physical frailty or deficit accumulation frailty per se, is useful to identify a
number of measurement domains that are important to the health care of older adults [42].
Indeed, this tool functions like a short version of a CGA, which in turn may be helpful in the
identification of more areas that may benefit from further diagnostic efforts or care
management plans.
Finally, the Clinical Frailty Scale is a rapid frailty screening tool that is scored between 1 (very
fit) and 9 (terminally ill) based on self-report of comorbidities and the need for help with
activities of daily living (ADLs) ( figure 1) [43].
PATHOPHYSIOLOGY
6 de 30 08-07-2023, 15:10
There is increasing evidence that dysregulated stress response systems, including immune,
endocrine, and energy response systems are important to the development of physical or
syndromic frailty. The basis of this dysregulation and ultimately frailty is hypothesized to be
driven by aging-related molecular changes, genetics, chronic environmental exposures, and
specific disease states ( figure 2) [44]. Sarcopenia, or age-related loss of skeletal muscle and
muscle strength, is a key physiologic component of frailty. Decline in skeletal muscle function
and mass are often consequences of age-related hormonal changes [45-48] and changes in
inflammatory pathways, including increase in inflammatory cytokines [49].
Endocrine — Multiple age-related hormone changes have been associated with frailty (see
"Growth hormone deficiency in adults"):
● Decreased growth hormone and insulin-like growth factor (IGF)-1 [45,50,51] – Associated
with lower strength and decreased mobility in a cohort of community-dwelling older
women [52].
● Decreased dehydroepiandrosterone sulfate (DHEA-S) [45] – DHEA-S likely plays a direct

role in maintaining muscle mass and indirectly prevents the activation of inflammatory
pathways that contribute to muscle decline [53].
● Increased cortisol levels [54] – May impact skeletal muscle and immune system
components.
● Decreased sex steroids – Evidence is mixed that lower levels of reproductive hormones
contribute to frailty [55-58].
● Decreased 25(OH) vitamin D [59].
Inflammation and the immune system — Direct biological connections between chronic

exposure to inflammatory mediators and pathophysiological tissues changes consistent with
frailty are increasingly evident.
● Serum levels of the proinflammatory cytokine interleukin (IL) 6 and C-reactive protein
(CRP), as well as white blood cell and monocyte counts, are elevated in community-
dwelling frail older adults [45,59-62]. In addition, elevated levels of these biomarkers in
female long-term care residents may predict worsening physical performance and gait
speed 12 months later [62]. IL-6 acts as a transcription factor and signal transducer that
adversely impacts skeletal muscle, appetite, adaptive immune system function, and
cognition [63] and contributes to anemia [64,65].
7 de 30 08-07-2023, 15:10
● Immune system activation may trigger the clotting cascade, with a demonstrated
association between frailty and clotting markers (factor VIII, fibrinogen and D-dimer)
[60].
● Frail older adults are less likely to mount an adequate immune response to influenza
vaccination [31].
Other stress response and metabolic systems
● Altered glucose metabolism [66]

● Dysregulation of the autonomic nervous system [67]
● Age-related changes in the renin-angiotensin system and in mitochondria likely impact
sarcopenia and inflammation, important components of frailty [68]
PATIENT EVALUATION
Patient history and examination — Identification of frailty in a variety of clinical practice

settings can guide additional assessment and aid in designing appropriate treatment plans.
A consensus group of delegates from international and US societies has recommended that all
persons over age 70 and adults with chronic disease or weight loss exceeding 5 percent over a
year be screened for frailty using available screening tools [19]. However, there are no
available data from trials investigating whether screening an unselected geriatric population
for frailty, based on age alone, will improve outcomes.
For patients in whom frailty is a potential concern, based on the clinician's observations and
reports from the patient and patient's family related to activity levels, diet, cognition, and
weight, the following should be ascertained:
● The patient history should focus on energy levels and excessive fatigue, ability to
perform or maintain physical activities like stair climbing, and the ability to get out of the
home and walk at least one block.
● In addition to examination appropriate to the patient's medical history and current

complaints, the physical examination should include a frailty screen such as those listed
above and an assessment of the patient's ability to rise from a firm chair five times
without use of arms, and the ability to walk across the room. Several frailty screening
tools are available. (See 'Instruments developed to identify frailty' above.)
Differential diagnosis — When considering the diagnosis of frailty, it is crucial to develop a
8 de 30 08-07-2023, 15:10
differential diagnosis list and rule out underlying medical or psychological issues that may be
driving signs and symptoms of frailty.
The most common conditions to be considered in older patients presenting with weight loss,
weakness, and impaired functional abilities include:
● Depression
● Malignancy – Lymphoma, multiple myeloma, occult solid tumors
● Rheumatologic disease – Polymyalgia rheumatica, vasculitis
● Endocrinologic disease – Hyper- or hypothyroidism, diabetes mellitus
● Cardiovascular disease – Hypertension, heart failure, coronary artery disease, peripheral
vascular disease
● Renal disease – Renal insufficiency
● Hematologic disease – Myelodysplasia, iron deficiency, and pernicious anemia
● Nutritional deficits – Vitamin deficiencies
● Neurologic disease – Parkinson disease, vascular dementia, serial lacunar infarcts
Laboratory testing — When evaluating a frail patient for the first time, laboratory testing
should be undertaken in order to rule out treatable conditions. A suggested initial screen
includes:
● Complete blood count

● Basic metabolic panel
● Liver biochemical tests, including albumin
● Vitamin B12
● Vitamin D
● Thyroid-stimulating hormone (TSH)
Consideration of workup for other conditions, such as polymyalgia rheumatica, vasculitis, or

congestive heart failure, should be based on the patient history and physical examination.
(See "Clinical manifestations and diagnosis of polymyalgia rheumatica" and "Overview of and
approach to the vasculitides in adults".)
MANAGEMENT
Specific care plans for frailty have not yet been extensively developed or tested. Despite this,
there are emerging strategies that can be utilized to help mitigate the daily impact of frailty on
quality of life and overall health status.
9 de 30 08-07-2023, 15:10
Establishing goals of care — Goal-setting with patients and their families is crucial in

providing care for the frail individual, establishing individual priorities, weighing risks and
benefits of interventions, and making decisions regarding aggressiveness of care. As the older
adult progresses along the frailty spectrum and develops more severe disease and/or
disability, it becomes increasingly important to tailor medical care to the needs of these
vulnerable patients while keeping the individual's values and goals in mind. Comprehensive
geriatric assessment (CGA) may help guide development of management and intervention
plans for frail patients [39]. Potential interventions that might be beneficial along the
continuum of frailty are shown in a figure ( figure 3). (See "Discussing goals of care" and
'Comprehensive geriatric assessment' below.)
For robust older patients, the medical practitioner should appropriately treat known chronic
diseases, manage intermittent acute illness and events, and assure age-appropriate screening
measures and preventive care [69].
In the moderately to severely frail patient, often "less is more." Aggressive screening or
intervention for non-life-threatening conditions may be rife with complications. Procedures or
hospitalizations may bring about unnecessary burden and decreased quality of life to a
patient who is already at great risk of morbidity and mortality [70]. In some cases, referral to
palliative care may be the most appropriate intervention. (See 'Palliative care' below.)
Nonetheless, frail older adults may benefit from interventions targeting specific components
of their frailty exam, and from CGA [71,72].
Interventions
Efficacy — A variety of interventions, particularly those including exercise, appear promising

in the prevention or reduction of frailty.
● A systematic review of the effectiveness of interventions to prevent frailty in older adults

summarized 21 randomized trials with a total of 5275 older adults and 33 interventions
[73]. The results showed that group, but not individual, physical exercise programs were
effective at reducing or postponing physical frailty as measured by any validated scale or
measurement or index (eg, frailty index, physical frailty measures, or Edmonton Frailty
Scale). Favorable effects of physical exercise, nutritional supplementation, and cognitive
training were also seen on a variety of frailty components.
● A secondary analysis of data from a three-year, randomized trial of 1637 French

community-dwelling older adults investigated whether a long-term multi-domain
lifestyle intervention of cognitive training, nutrition counseling, and advice on physical
10 de 30 08-07-2023, 15:10
activity was associated with severity and incidence of frailty measured by a comorbidity
or deficit accumulation index [74]. Compared with usual care, the intervention group had
a decreased risk of both developing increased numbers of comorbidities (hazard ratio
[HR] 0.72; 95% CI 0.55-0.93) and of persistent comorbidities/deficits (HR 0.53; 95% CI
0.33-0.85).
Exercise — The benefits of exercise in older adults include increased mobility, enhanced

performance of activities of daily living (ADLs), improved gait, decreased falls, improved bone
mineral density, and increased general wellbeing [75-78]. Studies suggest that even the
frailest older adults are likely to benefit from physical activity at almost any level that can be
safely tolerated [79,80]. In a systematic review of 33 trials conducted among adults over 65
years of age, yoga improved the frailty markers of gait speed, and lower extremity strength
and endurance when compared with education or inactive controls [81]. Yoga outcomes were
similar to those seen with the active controls of Tai chi or other forms of exercise. While
functionally limited or frail individuals may never be able to meet minimum recommended
activity levels for older adults, even modest activity and muscle strengthening can impact the
progression of functional limitations [79,80]. (See "Physical activity and exercise in older
adults", section on 'Functionally limited or frail'.)
Occupational therapy — In addition to exercise, formal occupational therapy has been

shown to be helpful, particularly in patients who are having difficulties with ADLs. A meta-
analysis of home and community-based occupational therapy for frail older adults showed
moderate improvements in the ability to perform ADLs, in social participation, and in mobility,
compared with baseline [82].
Nutritional supplementation — For patients with weight loss as a component of frailty,

attention should be focused on medication side effects, depression, difficulties with chewing
and swallowing, dependency on others for eating, and use of unnecessary dietary restrictions
(low-salt/low-fat) ( table 1). (See "Failure to thrive in older adults: Management", section on
'Weight loss'.)
In treatment of weight loss, oral nutritional supplements between meals (low-volume, high
caloric drinks or puddings) may be helpful in adding protein and calories. A meta-analysis of
studies of nutritional supplements showed that providing nutritional supplements to older
undernourished adults yielded small gains in weight (2.2 percent) [83].
Several meta-analyses of randomized trials show a reduction in falls with vitamin D

supplementation [84-88]. Vitamin D supplementation also may improve balance and preserve
muscle strength [89] and may play a role in preventing or treating frailty. In one report, lower
11 de 30 08-07-2023, 15:10
serum levels of 25-hydroxyvitamin D (<20.0 ng/mL) were associated with a higher prevalence
of frailty at baseline in a group of 1600 men over age 65 but did not predict greater risk for
developing frailty at 4.6 years [90]. Given that vitamin D appears to play an important role in
both muscle and nervous tissue maintenance with aging, further studies to evaluate the
association between vitamin D and frailty are indicated. The daily intake of vitamin D in older
adults should be at least 800 to 1000 international units. (See "Falls: Prevention in community-
dwelling older persons" and "Geriatric health maintenance", section on 'Vitamin D'.)
Medication review — Periodic evaluation of a patient's drug regimen is an essential

component of medical care for an older person, and it is especially important for patients who
are pre-frail or frail. Such a review may indicate the need for changes to prescribed drug
therapy ( table 2). Changes may include discontinuing a therapy prescribed for an indication
that no longer exists, discontinuing therapy with side effects that may be contributing to
frailty symptoms, substituting a therapy with a potentially safer agent, changing drug dose, or
adding a new medication. In reviewing medications, it is important to focus on the established
goals of care with the patient and caregivers. (See "Deprescribing".)
Ineffective interventions — Although activation of inflammatory pathways and

dysregulation in endocrine systems is believed to contribute to frailty (see 'Pathophysiology'
above), there are limited data on hormonal and antiinflammatory interventions for frailty, and
none have proven to be of significant benefit.
Several hormonal and nutritional interventions have been evaluated in related geriatric
conditions.
● Testosterone replacement increased muscle mass and strength in hypogonadal and

eugonadal men, especially in combination with exercise. Testosterone, however, may
lead to an unfavorable lipid profile and unpredictable effects on the prostate gland
[91,92]. We do not suggest routine testosterone replacement, in the absence of
demonstrable hypogonadism, as evidenced by clinical symptoms and signs consistent
with androgen deficiency and a subnormal morning (8 to 10 AM) serum testosterone
concentration on three separate occasions. (See "Testosterone treatment of male
hypogonadism", section on 'Appropriate candidates'.)
● Growth hormone or growth hormone releasing factor supplementation have not

demonstrated efficacy in improving function or other clinical outcomes in older adults
with age-related declines [93]. A systematic review found that the risks of exogenous
growth hormone outweigh potential benefits [94].
12 de 30 08-07-2023, 15:10
● Benefit from dehydroepiandrosterone sulfate (DHEA-S) supplementation in preventing or

treating frailty has not been demonstrated [95-97].
Further intervention studies in frailer, older individuals will be needed to determine the
effectiveness and potential harm of treatments that target endocrine or inflammatory biology
in frail older adults.
Palliative care — Diagnosing frailty helps identify those older adults at highest risk of adverse
health outcomes. Palliative care approaches may be helpful to alleviate symptoms of related
medical conditions and to help in consideration of the appropriateness of potential medical
and surgical interventions (such as chemotherapy or major surgery) and their impact on
mortality and quality of life for the frail older adult [98].
For those with advanced frailty and multiple comorbidities or those with failure to thrive, the
engagement of a palliative care team may help to identify methods to preserve or improve
quality of life and to clarify goals of care. (See "Benefits, services, and models of subspecialty
palliative care", section on 'Palliative care services'.)
Notably, in the United States, the Centers for Medicare and Medicaid Services (CMS) no longer
accept either debility or adult failure to thrive as a principal diagnosis for hospice services, and
these diagnoses should not be listed as the primary hospice diagnosis. However, progressive
inanition is one criterion which may be used to identify a likely life expectancy of six months or
less. (See "Hospice: Philosophy of care and appropriate utilization in the United States".)
MODEL SYSTEMS OF CARE
Care for frail older adults is frequently challenging, related to their increased disability and
multiple chronic diseases. This is further heightened in frail individuals who lack social
supports. An interdisciplinary team-based approach to care is often important in meeting the
needs of frail adults, who may represent the population most likely to benefit from specialized
and targeted comprehensive interventions [99].
Outcomes of interdisciplinary interventions are mixed, however. In one small randomized trial,
an interdisciplinary intervention involving screening, home visits, and occupational and
physical therapy tailored to the patient's support needs, compared with usual care, resulted in
no difference in disability outcome at six-month, one-year, and two-year assessments [100].
However, in another randomized clinical trial, multidisciplinary approaches that focused on
improvement of specific diagnostic criteria for physical frailty resulted in improvement in
13 de 30 08-07-2023, 15:10
frailty status and the potential for reduced health care costs [71,101].
A conceptual model of care has been outlined by one gerontology group, that proposes
several adjuncts and enhancements to the traditional one clinician/one patient visit [102].
Proposed practice changes include:
● Comanagement involving clinician and nurse practitioner or clinician assistant

● Support personnel (nurses, social workers) with specialized gerontology training
available as consultants
● Facilities accommodations – Adjustable height tables, clearance for wheelchair
maneuvering, microphones/headsets for hearing impaired, adjustable walker
● General staff education for communicating with frail older adults
● Team meetings to discuss complicated patients
● Full integration of electronic communications – Electronic medical records, email, secure
practice website, patient health questionnaires, templated notes
● Partnership and familiarity with community resources for housing, health promotion,
and caregiver support
Comprehensive geriatric assessment — Frail older adults are at highest risk in the general
population of older adults, and may be expected to derive maximum benefit from
comprehensive geriatric assessment (CGA). The overall goals of CGA are:
● To improve physical and psychological function

● To optimize medication prescribing and use
● To decrease nursing home placement, hospitalization, mortality risk
● To improve patient satisfaction
CGA involves an interdisciplinary care team that coordinates evaluation of an older patient and
develops a plan for integrated care [103]. The team usually consists of a geriatrician or other
medical practitioner knowledgeable in the care of older adults, nurse, social worker,
pharmacist, and an occupational or physical therapist. (See "Comprehensive geriatric
assessment" and "Comprehensive geriatric assessment for patients with cancer".)
Outpatient PACE — The frailest older adults in the United States may benefit from the
Medicare Program of All-inclusive Care for the Elderly (PACE). The goals of this model are to
improve function, overcome environmental challenges, and keep older adults living in their
communities by preventing institutionalization.
In this outpatient patient management model, primary care is delivered to community-

dwelling older adults by an interdisciplinary team in a day clinic setting [104]. The
14 de 30 08-07-2023, 15:10
interdisciplinary team includes a practitioner knowledgeable in geriatric medicine, nurses,

physical and occupational therapists, and social workers. Services provided include home
nursing, physical and occupational therapy, transportation, aide service, and adult day care.
Patients who enter the program receive complete long-term care and are followed until the
end of their lives, even if they eventually require placement in an assisted-living facility or
nursing home.
PACE was designated as a permanent Medicare program in 1997 because it was successful in
maintaining function and community-dwelling status and in providing lower-cost care
compared with traditional fee-for-service care [105].
Hospital care and ACE — Hospitalization increases risk for institutionalization and decrease in
quality of life for a frail older adult. Change in environment, exposure to new medications, and
immobility, combined with acute illness, can lead to devastating outcomes for these
vulnerable patients. Often, the decline in level of function and ability to care for oneself that
occurs during hospitalization persists after discharge [106,107]. In one study, frail individuals
had a sevenfold increased risk of progressing from no disability to mild disability within one
month of hospitalization, compared with non-frail patients (35 versus 7 percent) [108].
Acute Care for Elders (ACE) is a model of care for the acutely ill hospitalized older adult
designed to prevent functional decline and improve functional independence if decline has
occurred. The model typically includes a specially designed environment that is a more home-
like environment, patient-centered medical care that focuses on the prevention of disability,
and comprehensive discharge planning and management. In a randomized controlled trial of
1531 community-dwelling adults aged 70 and older, this model decreased the likelihood of
decline in activities of daily living (ADLs) or nursing home placement both at hospital
discharge and at 12 months without an increase in hospital length of stay or hospital costs
[109].
SUMMARY
● Frailty is an increasingly recognized clinical state of vulnerability with inherent increased

risk for adverse health outcomes, including functional decline and mortality. There is no
gold standard for diagnosing frailty. Importantly, old age itself does not define frailty.
(See 'Concepts and definitions' above.)
● The physiological basis of frailty is thought to be driven in part by the activation of

inflammatory pathways and dysregulation of neuroendocrine systems, which leads to
15 de 30 08-07-2023, 15:10
skeletal muscle decline. (See 'Pathophysiology' above.)
● An international consensus group has recommended that all persons over age 70, and
adults with chronic disease or weight loss exceeding 5 percent over a year, be screened
for frailty, though evidence supporting this approach is not robust. The FRAIL scale is one
tool that can be readily incorporated into history-taking, but multiple other screening
tools are available and have been validated. Physical examination should include
assessment of the patient's ability to rise from a firm chair five times without use of arms
and their ability to walk across the room. (See 'Patient evaluation' above and
'Instruments developed to identify frailty' above.)
● Goal-setting with patients and their families is crucial in providing care for the frail
individual, establishing individual priorities, weighing risks and benefits of interventions,
and making decisions regarding aggressiveness of care. Interventions have focused on
components of frailty, such as strength. Activity interventions have been shown to have a
positive impact on even the frailest older adults. To date, no biological or pharmaceutical
interventions are recommended for frailty per se, although biologically targeted
interventions may play a role in the future. (See 'Establishing goals of care' above and
'Interventions' above.)
● A variety of interventions, particularly those including exercise, appear promising in the

prevention or reduction of frailty. However, it is important to tailor interventions to the
individual, incorporating patient preferences and stage on the spectrum of frailty
( figure 3). Palliative care approaches may be considered in the frailest subset of older
adults. (See 'Interventions' above and 'Palliative care' above.)
● Clinical geriatric evaluation teams and specialized programs can play an important role
in improving the quality of life for older adults. (See 'Model systems of care' above.)
Use of UpToDate is subject to the Terms of Use.
REFERENCES
1. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J
Gerontol A Biol Sci Med Sci 2001; 56:M146.
2. Kiely DK, Cupples LA, Lipsitz LA. Validation and comparison of two frailty indexes: The
MOBILIZE Boston Study. J Am Geriatr Soc 2009; 57:1532.
3. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the
16 de 30 08-07-2023, 15:10
women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006; 61:262.
4. Woods NF, LaCroix AZ, Gray SL, et al. Frailty: emergence and consequences in women
aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc
2005; 53:1321.
5. Cawthon PM, Marshall LM, Michael Y, et al. Frailty in older men: prevalence, progression,
and relationship with mortality. J Am Geriatr Soc 2007; 55:1216.
6. Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older
cancer patients: a systematic review. Ann Oncol 2015; 26:1091.
7. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-
dwelling older persons: a systematic review. J Am Geriatr Soc 2012; 60:1487.
8. Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight

commonly used scales and comparison of their ability to predict all-cause mortality. J Am
Geriatr Soc 2013; 61:1537.
9. Lee DR, Kawas CH, Gibbs L, Corrada MM. Prevalence of Frailty and Factors Associated with
Frailty in Individuals Aged 90 and Older: The 90+ Study. J Am Geriatr Soc 2016; 64:2257.
10. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381:752.
11. Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in
older patients. J Am Coll Surg 2010; 210:901.
12. Garonzik-Wang JM, Govindan P, Grinnan JW, et al. Frailty and delayed graft function in
kidney transplant recipients. Arch Surg 2012; 147:190.
13. Kim DH, Kim CA, Placide S, et al. Preoperative Frailty Assessment and Outcomes at 6
Months or Later in Older Adults Undergoing Cardiac Surgical Procedures: A Systematic
Review. Ann Intern Med 2016; 165:650.
14. Li Y, Pederson JL, Churchill TA, et al. Impact of frailty on outcomes after discharge in older
surgical patients: a prospective cohort study. CMAJ 2018; 190:E184.
15. Rothenberg KA, Stern JR, George EL, et al. Association of Frailty and Postoperative
Complications With Unplanned Readmissions After Elective Outpatient Surgery. JAMA
Netw Open 2019; 2:e194330.
16. Hoogendijk EO, Stolz E, Oude Voshaar RC, et al. Trends in Frailty and Its Association With
Mortality: Results From the Longitudinal Aging Study Amsterdam, 1995-2016. Am J
Epidemiol 2021; 190:1316.
17. Kuffel RL, Morin RT, Covinsky KE, et al. Association of Frailty With Risk of Suicide Attempt
in a National Cohort of US Veterans Aged 65 Years or Older. JAMA Psychiatry 2023; 80:287.
17 de 30 08-07-2023, 15:10
18. Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of

frailty: a Delphi method based consensus statement: the frailty operative definition-
consensus conference project. J Gerontol A Biol Sci Med Sci 2013; 68:62.
19. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir
Assoc 2013; 14:392.
20. Xue QL, Tian J, Walston JD, et al. Discrepancy in Frailty Identification: Move Beyond
Predictive Validity. J Gerontol A Biol Sci Med Sci 2020; 75:387.
21. Sternberg SA, Wershof Schwartz A, Karunananthan S, et al. The identification of frailty: a
systematic literature review. J Am Geriatr Soc 2011; 59:2129.
22. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130:945.
23. Newman AB, Gottdiener JS, Mcburnie MA, et al. Associations of subclinical cardiovascular
disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56:M158.
24. Walston J. Frailty--the search for underlying causes. Sci Aging Knowledge Environ 2004;
2004:pe4.
25. Robinson TN, Walston JD, Brummel NE, et al. Frailty for Surgeons: Review of a National
Institute on Aging Conference on Frailty for Specialists. J Am Coll Surg 2015; 221:1083.
26. Walston J, Robinson TN, Zieman S, et al. Integrating Frailty Research into the Medical
Specialties-Report from a U13 Conference. J Am Geriatr Soc 2017; 65:2134.
27. Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: Systematic
characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev
2016; 26:53.
28. Aguayo GA, Donneau AF, Vaillant MT, et al. Agreement Between 35 Published Frailty
Scores in the General Population. Am J Epidemiol 2017; 186:420.
29. Walston JD, Bandeen-Roche K. Frailty: a tale of two concepts. BMC Med 2015; 13:185.
30. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older
adults in relation to deficit accumulation. J Am Geriatr Soc 2010; 58:681.
31. Yao X, Hamilton RG, Weng NP, et al. Frailty is associated with impairment of vaccine-
induced antibody response and increase in post-vaccination influenza infection in
community-dwelling older adults. Vaccine 2011; 29:5015.
32. Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J
Am Geriatr Soc 2008; 56:2211.
33. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A

Biol Sci Med Sci 2007; 62:722.
18 de 30 08-07-2023, 15:10
34. Avila-Funes JA, Amieva H, Barberger-Gateau P, et al. Cognitive impairment improves the
predictive validity of the phenotype of frailty for adverse health outcomes: the three-city
study. J Am Geriatr Soc 2009; 57:453.
35. Boyle PA, Buchman AS, Wilson RS, et al. Physical frailty is associated with incident mild
cognitive impairment in community-based older persons. J Am Geriatr Soc 2010; 58:248.
36. Robertson DA, Savva GM, Coen RF, Kenny RA. Cognitive function in the prefrailty and
frailty syndrome. J Am Geriatr Soc 2014; 62:2118.
37. Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of
falls, disability, fractures, and death in older women. Arch Intern Med 2008; 168:382.
38. Ensrud KE, Ewing SK, Cawthon PM, et al. A comparison of frailty indexes for the prediction
of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009; 57:492.
39. Turner G, Clegg A, British Geriatrics Society, et al. Best practice guidelines for the
management of frailty: a British Geriatrics Society, Age UK and Royal College of General
Practitioners report. Age Ageing 2014; 43:744.
40. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts
outcomes in middle aged African Americans. J Nutr Health Aging 2012; 16:601.
41. Woo J, Yu R, Wong M, et al. Frailty Screening in the Community Using the FRAIL Scale. J Am
Med Dir Assoc 2015; 16:412.
42. Rolfson DB, Majumdar SR, Tsuyuki RT, et al. Validity and reliability of the Edmonton Frail
Scale. Age Ageing 2006; 35:526.
43. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in
elderly people. CMAJ 2005; 173:489.
44. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a
better understanding of physiology and etiology: summary from the American Geriatrics
Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am
Geriatr Soc 2006; 54:991.
45. Leng SX, Cappola AR, Andersen RE, et al. Serum levels of insulin-like growth factor-I (IGF-I)
and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum
interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004; 16:153.
46. Valenti G, Denti L, Maggio M, et al. Effect of DHEAS on skeletal muscle over the life span:
the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59:466.
47. Wang H, Casaburi R, Taylor WE, et al. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I
receptor is decreased in sedentary chronic hemodialysis patients. Kidney Int 2005; 68:352.
19 de 30 08-07-2023, 15:10
48. Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med 2001; 137:231.
49. Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons:
associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci
Med Sci 2009; 64:1183.
50. Nass R, Thorner MO. Impact of the GH-cortisol ratio on the age-dependent changes in
body composition. Growth Horm IGF Res 2002; 12:147.
51. Lanfranco F, Gianotti L, Giordano R, et al. Ageing, growth hormone and physical
performance. J Endocrinol Invest 2003; 26:861.
52. Cappola AR, Xue QL, Ferrucci L, et al. Insulin-like growth factor I and interleukin-6
contribute synergistically to disability and mortality in older women. J Clin Endocrinol
Metab 2003; 88:2019.
53. Schmidt M, Naumann H, Weidler C, et al. Inflammation and sex hormone metabolism.
Ann N Y Acad Sci 2006; 1069:236.
54. Varadhan R, Walston J, Cappola AR, et al. Higher levels and blunted diurnal variation of
cortisol in frail older women. J Gerontol A Biol Sci Med Sci 2008; 63:190.
55. Poehlman ET, Toth MJ, Fishman PS, et al. Sarcopenia in aging humans: the impact of
menopause and disease. J Gerontol A Biol Sci Med Sci 1995; 50 Spec No:73.
56. O'Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: The
Massachusetts Male Aging Study (1987-2004). Exp Gerontol 2004; 39:975.
57. Travison TG, Nguyen AH, Naganathan V, et al. Changes in reproductive hormone
concentrations predict the prevalence and progression of the frailty syndrome in older
men: the concord health and ageing in men project. J Clin Endocrinol Metab 2011;
96:2464.
58. Mohr BA, Bhasin S, Kupelian V, et al. Testosterone, sex hormone-binding globulin, and
frailty in older men. J Am Geriatr Soc 2007; 55:548.
59. Puts MT, Visser M, Twisk JW, et al. Endocrine and inflammatory markers as predictors of
frailty. Clin Endocrinol (Oxf) 2005; 63:403.
60. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and
coagulation systems with and without clinical comorbidities: results from the
Cardiovascular Health Study. Arch Intern Med 2002; 162:2333.
61. Leng SX, Xue QL, Tian J, et al. Associations of neutrophil and monocyte counts with frailty
in community-dwelling disabled older women: results from the Women's Health and
Aging Studies I. Exp Gerontol 2009; 44:511.
20 de 30 08-07-2023, 15:10
62. Langmann GA, Perera S, Ferchak MA, et al. Inflammatory Markers and Frailty in Long-
Term Care Residents. J Am Geriatr Soc 2017; 65:1777.
63. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life
diseases, and frailty. Annu Rev Med 2000; 51:245.
64. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am
Geriatr Soc 2003; 51:S18.
65. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as

physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc
2002; 50:1268.
66. Kalyani RR, Varadhan R, Weiss CO, et al. Frailty status and altered glucose-insulin
dynamics. J Gerontol A Biol Sci Med Sci 2012; 67:1300.
67. Varadhan R, Chaves PH, Lipsitz LA, et al. Frailty and impaired cardiac autonomic control:
new insights from principal components aggregation of traditional heart rate variability
indices. J Gerontol A Biol Sci Med Sci 2009; 64:682.
68. Burks TN, Andres-Mateos E, Marx R, et al. Losartan restores skeletal muscle remodeling
and protects against disuse atrophy in sarcopenia. Sci Transl Med 2011; 3:82ra37.
69. Goldberg TH, Chavin SI. Preventive medicine and screening in older adults. J Am Geriatr
Soc 1997; 45:344.
70. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for
individualized decision making. JAMA 2001; 285:2750.
71. Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention

reduces frailty in older people: randomized trial. BMC Med 2013; 11:65.
72. Lin HC, Wang CH, Tsai FJ, et al. Enterovirus infection is associated with an increased risk of
childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study.
Diabetologia 2015; 58:79.
73. Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent

pre-frailty and frailty progression in older adults: a systematic review. JBI Database
System Rev Implement Rep 2018; 16:140.
74. de Souto Barreto P, Rolland Y, Maltais M, et al. Associations of Multidomain Lifestyle

Intervention with Frailty: Secondary Analysis of a Randomized Controlled Trial. Am J Med
2018; 131:1382.e7.
75. Daley MJ, Spinks WL. Exercise, mobility and aging. Sports Med 2000; 29:1.
76. Spirduso WW, Cronin DL. Exercise dose-response effects on quality of life and
21 de 30 08-07-2023, 15:10
independent living in older adults. Med Sci Sports Exerc 2001; 33:S598.
77. Keysor JJ. Does late-life physical activity or exercise prevent or minimize disablement? A
critical review of the scientific evidence. Am J Prev Med 2003; 25:129.
78. Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly
patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative
Studies of Intervention Techniques. JAMA 1995; 273:1341.
79. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation
for physical frailty in very elderly people. N Engl J Med 1994; 330:1769.
80. Miller ME, Rejeski WJ, Reboussin BA, et al. Physical activity, functional limitations, and
disability in older adults. J Am Geriatr Soc 2000; 48:1264.
81. Loewenthal J, Innes KE, Mitzner M, et al. Effect of Yoga on Frailty in Older Adults : A
Systematic Review. Ann Intern Med 2023; 176:524.
82. De Coninck L, Bekkering GE, Bouckaert L, et al. Home- and Community-Based

Occupational Therapy Improves Functioning in Frail Older People: A Systematic Review. J
Am Geriatr Soc 2017; 65:1863.
83. Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation in elderly
people at risk from malnutrition. Cochrane Database Syst Rev 2009; :CD003288.
84. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the
risk of fall and fracture: a meta-analysis. QJM 2007; 100:185.
85. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a
meta-analysis. JAMA 2004; 291:1999.
86. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with
supplemental and active forms of vitamin D: a meta-analysis of randomised controlled
trials. BMJ 2009; 339:b3692.
87. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older
people living in the community. Cochrane Database Syst Rev 2009; :CD007146.
88. Cameron ID, Murray GR, Gillespie LD, et al. Interventions for preventing falls in older
people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010;
:CD005465.
89. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an

authentic strength preserving hormone. Mol Aspects Med 2005; 26:203.
90. Ensrud KE, Blackwell TL, Cauley JA, et al. Circulating 25-hydroxyvitamin D levels and frailty
in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 2011; 59:101.
22 de 30 08-07-2023, 15:10
91. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science
1997; 278:419.
92. Tenover JS. Androgen replacement therapy to reverse and/or prevent age-associated
sarcopenia in men. Baillieres Clin Endocrinol Metab 1998; 12:419.
93. Lamberts SW. The somatopause: to treat or not to treat? Horm Res 2000; 53 Suppl 3:42.
94. Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth
hormone in the healthy elderly. Ann Intern Med 2007; 146:104.
95. Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord 2005; 6:101.
96. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in
elderly men. N Engl J Med 2006; 355:1647.
97. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate,
and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad
Sci U S A 2000; 97:4279.
98. Maida V, Devlin M. Frailty, thy name is Palliative! CMAJ 2015; 187:1312.
99. Ko FC. The clinical care of frail, older adults. Clin Geriatr Med 2011; 27:89.
100. Metzelthin SF, van Rossum E, de Witte LP, et al. Effectiveness of interdisciplinary primary
care approach to reduce disability in community dwelling frail older people: cluster
randomised controlled trial. BMJ 2013; 347:f5264.
101. Fairhall N, Sherrington C, Kurrle SE, et al. Economic evaluation of a multifactorial,

interdisciplinary intervention versus usual care to reduce frailty in frail older people. J Am
Med Dir Assoc 2015; 16:41.
102. Ganz DA, Fung CH, Sinsky CA, et al. Key elements of high-quality primary care for
vulnerable elders. J Gen Intern Med 2008; 23:2018.
103. Urdangarin CF. Comprehensive Geriatric Assessment and Management. In: Assessing Old
er Persons, Kane RL, Kane RA (Eds), Oxford University Press, New York 2000.
104. Eng C, Pedulla J, Eleazer GP, et al. Program of All-inclusive Care for the Elderly (PACE): an
innovative model of integrated geriatric care and financing. J Am Geriatr Soc 1997; 45:223.
105. Mukamel DB, Peterson DR, Temkin-Greener H, et al. Program characteristics and
enrollees' outcomes in the Program of All-Inclusive Care for the Elderly (PACE). Milbank Q
2007; 85:499.
106. Palmer RM, Counsell S, Landefeld CS. Clinical intervention trials: the ACE unit. Clin Geriatr
Med 1998; 14:831.
107. Sager MA, Franke T, Inouye SK, et al. Functional outcomes of acute medical illness and
23 de 30 08-07-2023, 15:10
hospitalization in older persons. Arch Intern Med 1996; 156:645.
108. Gill TM, Allore HG, Gahbauer EA, Murphy TE. Change in disability after hospitalization or
restricted activity in older persons. JAMA 2010; 304:1919.
109. Counsell SR, Holder CM, Liebenauer LL, et al. Effects of a multicomponent intervention on
functional outcomes and process of care in hospitalized older patients: a randomized
controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc
2000; 48:1572.
Topic 3010 Version 51.0
24 de 30 08-07-2023, 15:10
GRAPHICS
Clinical Frailty Scale
IADLs: instrumental activities of daily living.
Reproduced with permission from: Dalhousie University. Clinical Frailty Scale. Available at: https://www.dal.ca/sites/gmr/our-tools/clinical-
frailty-scale.html (Accessed on October 20, 2020). Copyright © 2020 Rockwood K, et al.
Graphic 129047 Version 1.0
25 de 30 08-07-2023, 15:10
Hypothesized model of frailty and adverse health outcomes
CRP: C-reactive protein; IL: interleukin; IGF: insulin-like growth factor; DHEA-S:
dehydroepiandrosterone sulfate.
Reproduced with permission from: Walston J, Hadley EC, Ferrucci L, et al. Research Agenda for Frailty in Older
Adults: Towards a Better Understanding of Physiology and Etiology. J Am Geriatr Soc 2006; 54:991. Copyright ©
2006 Wiley-Blackwell.
26 de 30 08-07-2023, 15:10
Potential interventions along the spectrum of frailty in older

adults
ACE unit: Acute Care for Elders unit; GEM: Geriatric Evaluation and Management;
PACE: Program for All-Inclusive Care of the Elderly.
Modiﬁed with permission from: Walston JD, Fried LP. Frailty and its Implications for Care. Chapter 9.
In: Geriatric Palliative Care, Morrison RS, Meire DE. Oxford University Press, New York 2003. p.93.
Copyright ©2003 Oxford University Press.
27 de 30 08-07-2023, 15:10
Mnemonic for common causes of malnutrition in older adults
MEALS ON WHEELS
M Medications
E Emotional problems (depression)
A Anorexia (nervosa or tardive)
L Late-life paranoia or alcoholism
S Swallowing disorders
O Oral factors
N No money
W Wandering (in patients with dementia)
H Hyperthyroidism, hyperparathyroidism
E Entry problems/malabsorption
E Eating problems (severe tremor, stroke, weakness)
L Low-salt or low-cholesterol diets
S Shopping and food preparation problems
Reproduced with permission from: Saint Louis University Geriatric Evaluation Mnemonics Screening Tools. Compiled by
faculty from Saint Louis University Geriatrics Division. Copyright ©2002 Saint Louis University.
28 de 30 08-07-2023, 15:10
A step-wise approach to reviewing medications for older adults
Approach
Review current drug therapy
Discontinue potentially unnecessary therapy
Consider adverse drug events as a potential cause for any new symptom
Consider nonpharmacologic approaches
Substitute with safer alternatives
Reduce the dose
Use beneficial therapies when indicated
Reproduced with permission from: Rochon PA, Gurwitz JH. Drug Therapy. The Lancet 1995; 346:32. Copyright © 1995
Elsevier.
29 de 30 08-07-2023, 15:10
Contributor Disclosures
Jeremy D Walston, MD No relevant financial relationship(s) with ineligible companies to
disclose. Kenneth E Schmader, MD No relevant financial relationship(s) with ineligible companies to
disclose. Jane Givens, MD, MSCE No relevant financial relationship(s) with ineligible companies to
disclose.
Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these
are addressed by vetting through a multi-level review process, and through requirements for references
to be provided to support the content. Appropriately referenced content is required of all authors and
must conform to UpToDate standards of evidence.
Conflict of interest policy
30 de 30 08-07-2023, 15:10

Frailty - UpToDate

Uploaded by

Copyright:

Available Formats

Frailty - UpToDate

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Frailty - UpToDate

Uploaded by

Copyright:

Available Formats

Frailty - UpToDate https://www.uptodate.com/contents/frailty/print?search=frailty&source=...

Official reprint from UpToDate®

Literature review current through: Jun 2023.

Frailty is most often defined as an aging-related syndrome of physiological decline,

HEALTH CONSEQUENCES AND MORTALITY

Frailty is associated with increased mortality:

● In the longitudinal Women's Health Initiative Observational Study, mortality was

CONCEPTS AND DEFINITIONS

● Deficit accumulation frailty or index frailty was developed around a conceptual

commonalities includes [18,19,21,22]:

● Multiple factors (medical, environmental, educational, and psychological background)

Instruments developed to identify frailty — Efforts to incorporate frailty measurement

● Weight loss (≥5 percent of body weight in last year)

Although there may be biological connections between mild cognitive impairment/dementia

● Weight loss of 5 percent in last year;

● Decreased dehydroepiandrosterone sulfate (DHEA-S) [45] – DHEA-S likely plays a direct

● Decreased 25(OH) vitamin D [59].

Inflammation and the immune system — Direct biological connections between chronic

Other stress response and metabolic systems

● Altered glucose metabolism [66]

Patient history and examination — Identification of frailty in a variety of clinical practice

● In addition to examination appropriate to the patient's medical history and current

Differential diagnosis — When considering the diagnosis of frailty, it is crucial to develop a

● Complete blood count

Consideration of workup for other conditions, such as polymyalgia rheumatica, vasculitis, or

Establishing goals of care — Goal-setting with patients and their families is crucial in

Efficacy — A variety of interventions, particularly those including exercise, appear promising

● A systematic review of the effectiveness of interventions to prevent frailty in older adults

● A secondary analysis of data from a three-year, randomized trial of 1637 French

Exercise — The benefits of exercise in older adults include increased mobility, enhanced

Occupational therapy — In addition to exercise, formal occupational therapy has been

Nutritional supplementation — For patients with weight loss as a component of frailty,

Several meta-analyses of randomized trials show a reduction in falls with vitamin D

Medication review — Periodic evaluation of a patient's drug regimen is an essential

Ineffective interventions — Although activation of inflammatory pathways and

● Testosterone replacement increased muscle mass and strength in hypogonadal and

● Growth hormone or growth hormone releasing factor supplementation have not

● Benefit from dehydroepiandrosterone sulfate (DHEA-S) supplementation in preventing or

MODEL SYSTEMS OF CARE

● Comanagement involving clinician and nurse practitioner or clinician assistant

● To improve physical and psychological function

In this outpatient patient management model, primary care is delivered to community-

interdisciplinary team includes a practitioner knowledgeable in geriatric medicine, nurses,

● Frailty is an increasingly recognized clinical state of vulnerability with inherent increased

● The physiological basis of frailty is thought to be driven in part by the activation of

skeletal muscle decline. (See 'Pathophysiology' above.)

● A variety of interventions, particularly those including exercise, appear promising in the

Use of UpToDate is subject to the Terms of Use.

3. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the

8. Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight

18. Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of

33. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A

65. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as

71. Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention

73. Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent

74. de Souto Barreto P, Rolland Y, Maltais M, et al. Associations of Multidomain Lifestyle

82. De Coninck L, Bekkering GE, Bouckaert L, et al. Home- and Community-Based

89. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an

101. Fairhall N, Sherrington C, Kurrle SE, et al. Economic evaluation of a multifactorial,

hospitalization in older persons. Arch Intern Med 1996; 156:645.